Lv4
550 积分 2021-07-07 加入
1079-P: FIB-4 Forward—Enhancing MASLD Screening in Patients with Type 2 Diabetes Using an EHR-Based Tool
7小时前
求助中
FIB-4 as a screening and disease monitoring method in pre-fibrotic stages of metabolic dysfunction-associated fatty liver disease (MASLD)
8小时前
已完结
P04 Pilot study to identify undiagnosed NAFLD with moderate to advanced fibrosis in a primary care population
8小时前
求助中
Towards collaborative management of non‐alcoholic fatty liver disease: a ‘real‐world’ pathway for fibrosis risk assessment in primary care
8小时前
待确认
Fibrosis-4 (FIB-4) score at the primary care level: an analysis of over 160 000 blood samples
11小时前
待确认
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
2个月前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2个月前
已完结
皖公网安备34019202002308
